Neighbourly Pharmacy Inc. ("
Neighbourly" or the
"
Company"), Canada’s largest and fastest growing
network of community pharmacies, today announced that the Company,
along with certain entities affiliated with Persistence Capital
Partners (collectively, the
“Selling
Shareholders”), have entered into an agreement with
Scotiabank and RBC Capital Markets (the
"
Underwriters") pursuant to which the Underwriters
have agreed to purchase an aggregate of 4,230,000 common
shares (the "
Common Shares") of Neighbourly, at a
price of $30.75 per Common Share, on a bought deal basis, for
aggregate gross proceeds of approximately $130 million to the
Company and the Selling Shareholders.
Under the agreement, 977,000 Common Shares
will be issued from treasury by Neighbourly for gross proceeds to
the Company of approximately $30 million (the "Treasury
Offering") and an aggregate of 3,253,000 Common
Shares will be offered by the Selling Shareholders for aggregate
gross proceeds to the Selling Shareholders of approximately $100
million (the "Secondary Offering," or together
with the Treasury Offering, the “Offering”).
The Selling Shareholders have also granted the
Underwriters an over-allotment option, exercisable for a period of
30 days from the date of the closing of the Offering, to purchase
up to an additional 15% of the Common Shares to be sold pursuant to
the Offering at the offering price to cover over-allotments, if
any, and for market stabilization purposes.
The net proceeds of the Treasury Offering will
be used to strengthen Neighbourly’s financial position and allow
the Company to continue to make accretive acquisitions at a similar
pace to historical levels. Net proceeds from the Secondary Offering
will be paid directly to the Selling Shareholders. Neighbourly will
not receive any of the proceeds of the sale of Common Shares by the
Selling Shareholders.
The Common Shares distributed pursuant to the
Offering and, if applicable, the over-allotment option, will be
offered in all provinces and territories of Canada by way of a
prospectus supplement (the “Prospectus
Supplement”) to a short form base shelf prospectus (the
“Final Base Shelf Prospectus”). The Common Shares
distributed pursuant to the Offering will also be offered in the
United States by way of private placement to “qualified
institutional buyers” in reliance upon the exemption from
registration provided by Rule 144A under the U.S. Securities Act of
1933, as amended (the “1933 Act”).
Neighbourly will file a preliminary short form
base shelf prospectus (the “Preliminary Base Shelf
Prospectus”) no later than October 12, 2021. Such
Preliminary Base Shelf Prospectus, which remains subject to the
review of the Canadian securities regulatory authorities, will
qualify the distribution by way of prospectus in Canada of up to
$500 million of common shares, debt securities, preferred shares,
warrants, subscription receipts, units, or any combination thereof,
during the 25-month period during which the Final Base Shelf
Prospectus will be effective. Concurrent with the filing of the
Preliminary Base Shelf Prospectus, the Company will also file a
Preliminary Prospectus Supplement with Canadian securities
regulatory authorities in order to qualify the Common Shares to be
distributed pursuant to the Offering as described above. The
Offering is expected to close on or about October 25, 2021 and is
subject to certain customary conditions including, but not limited
to, the receipt of all regulatory approvals including the approval
of the Toronto Stock Exchange.
Prospective investors should read the
Preliminary and Final Base Shelf Prospectus, Prospectus Supplement
and the documents incorporated by reference therein before
investing in the Common Shares. When available, these documents may
be accessed for free on SEDAR at www.sedar.com.
Persistence Capital Partners currently owns or
controls, directly or indirectly, 21,100,922 Common Shares
representing approximately 63.1% of the currently issued and
outstanding Common Shares. Following the closing of the Offering
(assuming no exercise of the over-allotment option), Persistence
Capital Partners will own or control, directly or indirectly,
17,847,922 Common Shares, representing approximately 51.9% of the
issued and outstanding Common Shares.
As the Canadian pharmacy industry begins to
recover from the impact of the pandemic, Neighbourly has
continued to execute upon its strategy of growth by acquisition,
and its acquisition pipeline remains robust. This
strategy drove the Company's financial results for the second
quarter of fiscal 2022, which will be reported in detail on October
26, 2021. Based on currently available preliminary information, the
Company anticipates reporting Revenue of approximately $90.7
million, Net Loss of approximately $3.4 million and Adjusted
EBITDA1 of approximately $10.0 million for the second quarter of
fiscal 2022, which would represent improvements of 54%, 12.4% and
52%, respectively, when compared to the second quarter of fiscal
2021. Adjusted EBITDA for the second quarter of fiscal 2022 is
expected to include corporate, general, and administrative costs of
approximately $3.6 million, which reflect both the Company’s
accelerated pace of acquisition and increased costs
associated with becoming a public company. Neighbourly anticipates
that its operating leverage will continue to improve as the Company
continues to expand its network. As reported earlier today,
Neighbourly announced the acquisition of 21 additional pharmacy
locations which are expected to close within Neighbourly’s third
fiscal quarter, pending customary regulatory approvals.
No securities regulatory authority has either
approved or disapproved the contents of this news release. The
securities offered pursuant to the Offering have not been, nor will
they be, registered under the 1933 Act and may not be offered, sold
or delivered, directly or indirectly, in the United States, or to,
or for the account or benefit of, "U.S. persons" (as defined in
Regulation S under the 1933 Act), except pursuant to an exemption
from the registration requirements of the 1933 Act. This news
release does not constitute an offer to sell or a solicitation of
an offer to buy any securities in the United States or to, or for
the account or benefit of, U.S. persons. This news release does not
constitute an offer to sell or a solicitation of an offer to buy
any securities in any jurisdiction in which such offer,
solicitation, or sale would be unlawful.
About Neighbourly Pharmacy
Inc.
Neighbourly is Canada’s largest and fastest
growing network of community pharmacies. United by their patient
first focus and their role as essential and trusted healthcare hubs
within their communities, Neighbourly’s pharmacies strive to
provide accessible healthcare with a personal touch. Since 2015,
Neighbourly has expanded its diversified national footprint to
include 167 locations (on a pro forma basis, after giving effect to
recently announced proposed acquisitions), reinforcing the
Company’s reputation as the industry’s acquirer of choice.
Forward-Looking Statements
This news release contains “forward-looking
information” and “forward-looking statements” (collectively,
“forward-looking information”) within the meaning of applicable
securities laws. Forward-looking information may relate to our
future financial results and may include information regarding our
financial position, business strategy, growth strategies, financial
results, taxes, dividend policy, plans and objectives. In some
cases, forward-looking information can be identified by the use of
forward-looking terminology such as “expects”, “estimates”,
“outlook”, “forecasts”, “projection”, “prospects”, “intends”,
“anticipates”, “believes”, or variations of such words and phrases
or statements that certain actions, events or results “may”,
“could”, “would”, “might”, “will”, “will be taken”, “occur” or “be
achieved”. In addition, any statements that refer to expectations,
intentions, projections or other characterizations of future events
or circumstances contain forward-looking information. Statements
containing forward-looking information are not historical facts but
instead represent management’s expectations, estimates and
projections regarding future events or circumstances.
Forward-looking information in this news release includes, among
other things, statements relating to the proposed Offering, the
terms of the Offering and use of proceeds from the Treasury
Offering, the filing of the Preliminary Base Shelf Prospectus and
the Prospectus Supplement qualifying the Common Shares under the
Offering, and the closing of the Offering, statements relating to
the expected completion of recently announced acquisitions and
timing thereof, and statements relating to the pursuit of accretive
acquisitions at a similar pace to historical levels and the
Company’s anticipation of improving operating leverage as it
continues to expand its network.
Forward-looking information is necessarily based
on a number of opinions, estimates and assumptions that the Company
considered appropriate and reasonable as of the date such
statements are made in light of its experience and perception of
historical trends, current conditions and expected future
developments. Such estimates and assumptions include the
satisfaction of all conditions of closing and the successful
completion of the Offering and recently announced acquisitions
within the anticipated timeframe, including receipt of regulatory
approvals (including stock exchange). Further, forward-looking
information is subject to known and unknown risks, uncertainties,
assumptions and other factors that may cause the actual results,
level of activity, performance or achievements to be materially
different from those expressed or implied by such forward-looking
information, including but not limited to risks and uncertainties
related to the Offering and recently announced acquisitions,
including the failure to receive or delay in receiving regulatory
approvals (including stock exchange) or otherwise satisfy the
conditions to the completion of the Offering or such acquisitions,
in a timely manner, or at all, which is subject to numerous
factors, many of which are beyond the Company’s control, as well as
other factors discussed or referred to in the Company’s
Management's Discussion and Analysis for the twelve-weeks ended
June 19, 2021 and under the heading “Risk Factors” in the final
long form prospectus dated May 17, 2021 filed in connection with
the initial public offering of Neighbourly, both of which are
available on SEDAR at www.sedar.com under the Company’s profile. If
any of these risks or uncertainties materialize, or if the
opinions, estimates, or assumptions underlying the forward-looking
information prove incorrect, actual results or future events might
vary materially from those anticipated in the forward-looking
information.
Although we have attempted to identify important
risk factors that could cause actual results to differ materially
from those contained in forward-looking information, there may be
other risk factors not presently known to us or that we presently
believe are not material that could also cause actual results or
future events to differ materially from those expressed in such
forward-looking information. There can be no assurance that such
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
information. No forward-looking statement is a guarantee of future
results. Accordingly, you should not place undue reliance on
forward-looking information, which speaks only as of the date made.
The forward-looking information contained in this news release
represents the Company’s expectations as of the date of this news
release (or as the date they are otherwise stated to be made) and
are subject to change after such date. However, the Company
disclaims any intention or obligation or undertaking to update or
revise any forward-looking information whether as a result of new
information, future events or otherwise, except as required under
applicable securities laws in Canada. All of the forward-looking
information contained in this news release is expressly qualified
by the foregoing cautionary statements.
Preliminary Estimated Results
(unaudited)
All figures and information indicated
herein with respect to the second quarter of the fiscal year ending
March 26, 2022 are preliminary, have not been reviewed by our
auditors and are subject to change as our financial results for the
quarter are finalized. Such information reflects our
preliminary estimates with respect to such results based on
currently available information, is not a comprehensive statement
of our financial results and is subject to completion of our
financial closing procedures. Our financial closing procedures are
not yet complete and, as a result, our actual results may change as
a result of such financial closing procedures, final adjustments,
management’s review of results, and other developments that may
arise between now and the time the financial results are finalized,
and results could be materially different than the estimates set
forth herein. These estimates should not be viewed as a substitute
for our consolidated financial statements prepared in accordance
with International Financial Reporting Standards
(“IFRS”) which will be filed with the Canadian
securities regulatory authorities on October 26, 2021. Further, our
preliminary estimated results are based on a number of assumptions,
and are not necessarily indicative of the results to be expected
for any future period as a result of various factors, including,
but not limited to, those discussed or referred to in the Company’s
Management's Discussion and Analysis for the 12-week period ended
June 19, 2021 and under the heading “Risk Factors” in the final
long form prospectus dated May 17, 2021 filed in connection with
the initial public offering of Neighbourly, both of which are
available on SEDAR at www.sedar.com under the Company’s
profile.
Non-IFRS Measures
This news release makes reference to certain
non-IFRS measures, such as Adjusted EBITDA. Please refer to the
Company’s Management's Discussion and Analysis dated August 3, 2021
for the 12-week period ended June 19, 2021, which is available
under the Company’s profile on SEDAR at www.sedar.com, for an
explanation of the composition of those non-IFRS measures, an
explanation of how these non-IFRS measures provide useful
information to investors and the additional purposes for which
management uses these non-IFRS financial measures, under “Non-IFRS
Measures” and “Reconciliation of Non-IFRS Measures”, which sections
are incorporated by reference in this news release. These measures
are not recognized under IFRS and do not have a standardized
meaning prescribed by IFRS and are therefore unlikely to be
comparable to similar measures presented by other companies.
Reconciliation from IFRS to Non-IFRS
Measures
The following table provides a reconciliation of loss to
Adjusted EBITDA for the periods indicated:
|
|
Second Quarter |
in
000's |
|
2022 (1) |
2021 |
|
|
|
|
|
Loss and comprehensive
loss for the period |
|
(3,394 |
) |
(3,872 |
) |
Income tax expense (recovery) |
|
774 |
|
60 |
|
Finance (income) costs, net |
|
2,003 |
|
1,611 |
|
Fair value changes of financial liabilities |
|
- |
|
3,698 |
|
Depreciation and amortization |
|
5,414 |
|
3,795 |
|
Impairment loss |
|
23 |
|
- |
|
Acquisition, transaction and integration costs |
|
3,567 |
|
1,242 |
|
Share-based compensation |
|
1,585 |
|
46 |
|
|
|
|
|
Adjusted EBITDA |
|
9,972 |
|
6,580 |
|
|
|
|
|
(1) Preliminary estimates |
|
|
|
1 Adjusted EBITDA is a non-IFRS financial measure and does not
have any standard meaning under IFRS. Refer to "Non-IFRS Measures"
of this news release for additional information.
Neighbourly Pharmacy (TSX:NBLY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Neighbourly Pharmacy (TSX:NBLY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025